Analysis Article • Apr 20
Have your own idea? Try our Stock Screener
Singaporean (SGX) Healthcare Sector Analysis
UpdatedJul 01, 2026
DataAggregated Company Financials
Companies29
- 7D-1.8%
- 3M-3.6%
- 1Y22.7%
- YTD-7.2%
Over the last 7 days, the Healthcare industry has dropped 1.8%, driven by UltraGreen.ai declining 6.7%. Over the past 12 months, the industry was up 25%. Earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Singaporean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Jul 2026 | S$11.4b | S$3.2b | S$342.3m | 19.5x | 33.3x | 3.5x |
| Fri, 29 May 2026 | S$11.9b | S$3.2b | S$343.1m | 17.2x | 34.5x | 3.7x |
| Sun, 26 Apr 2026 | S$12.2b | S$3.2b | S$348.2m | 17.7x | 34.9x | 3.8x |
| Tue, 24 Mar 2026 | S$11.3b | S$3.2b | S$352.6m | 15.8x | 32.1x | 3.5x |
| Thu, 19 Feb 2026 | S$10.3b | S$3.1b | S$292.7m | 15.8x | 35.3x | 3.3x |
| Sat, 17 Jan 2026 | S$10.3b | S$3.1b | S$296.3m | 15x | 34.7x | 3.3x |
| Mon, 15 Dec 2025 | S$9.7b | S$3.1b | S$295.2m | 15.1x | 32.8x | 3.1x |
| Wed, 12 Nov 2025 | S$9.5b | S$3.1b | S$294.9m | 15.1x | 32.2x | 3.1x |
| Fri, 10 Oct 2025 | S$9.4b | S$3.1b | S$306.6m | 16.2x | 30.8x | 3.1x |
| Sun, 07 Sep 2025 | S$9.9b | S$3.2b | S$350.9m | 15.5x | 28.1x | 3.1x |
| Tue, 05 Aug 2025 | S$9.4b | S$3.1b | S$372.2m | 13.7x | 25.3x | 3.1x |
| Thu, 03 Jul 2025 | S$9.0b | S$3.1b | S$373.7m | 12.7x | 24.1x | 2.9x |
| Sat, 31 May 2025 | S$8.6b | S$3.1b | S$371.7m | 12.9x | 23.1x | 2.8x |
| Mon, 28 Apr 2025 | S$9.0b | S$3.1b | S$371.8m | 12.3x | 24.1x | 2.9x |
| Wed, 26 Mar 2025 | S$9.2b | S$3.1b | S$372.8m | 12.6x | 24.7x | 3x |
| Fri, 21 Feb 2025 | S$8.7b | S$3.0b | S$348.4m | 16.3x | 24.9x | 2.9x |
| Sun, 19 Jan 2025 | S$8.7b | S$3.0b | S$349.9m | 16.5x | 24.9x | 2.9x |
| Tue, 17 Dec 2024 | S$8.8b | S$3.0b | S$350.2m | 16.4x | 25x | 2.9x |
| Thu, 14 Nov 2024 | S$8.6b | S$3.0b | S$344.2m | 16.3x | 25.1x | 2.9x |
| Sat, 12 Oct 2024 | S$8.6b | S$2.9b | S$360.0m | 16.2x | 23.8x | 2.9x |
| Mon, 09 Sep 2024 | S$8.4b | S$3.0b | S$362.4m | 16.5x | 23.3x | 2.8x |
| Wed, 07 Aug 2024 | S$8.3b | S$2.9b | S$334.3m | 17.5x | 24.7x | 2.8x |
| Fri, 05 Jul 2024 | S$8.7b | S$2.9b | S$364.5m | 17x | 23.9x | 3x |
| Sun, 02 Jun 2024 | S$8.6b | S$2.9b | S$368.2m | 16.4x | 23.4x | 3x |
| Tue, 30 Apr 2024 | S$8.5b | S$2.9b | S$357.6m | 16.1x | 23.6x | 2.9x |
| Thu, 28 Mar 2024 | S$8.5b | S$2.9b | S$411.8m | 14.2x | 20.7x | 2.9x |
| Sat, 24 Feb 2024 | S$8.5b | S$2.9b | S$359.6m | 13.8x | 23.7x | 3x |
| Mon, 22 Jan 2024 | S$9.0b | S$3.2b | S$441.7m | 14.8x | 20.3x | 2.8x |
| Wed, 20 Dec 2023 | S$9.4b | S$3.2b | S$440.6m | 15.4x | 21.3x | 2.9x |
| Fri, 17 Nov 2023 | S$11.8b | S$4.3b | S$578.8m | 15.8x | 20.3x | 2.7x |
| Sun, 15 Oct 2023 | S$12.3b | S$4.4b | S$595.8m | 15.9x | 20.6x | 2.8x |
| Tue, 12 Sep 2023 | S$12.6b | S$4.4b | S$598.6m | 16.1x | 21.1x | 2.9x |
| Thu, 10 Aug 2023 | S$13.2b | S$4.4b | S$627.7m | 16x | 21.1x | 3x |
| Sat, 08 Jul 2023 | S$13.4b | S$4.5b | S$646.6m | 15.5x | 20.7x | 3x |
Price to Earnings Ratio
20.7x
Current Industry PE
- Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 33.6x which is higher than its 3-year average PE of 25.8x.
- The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years,
- Revenues have also declined 10% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare sector?
| SG Market | -0.63% | |
| Healthcare | -1.78% | |
| Healthcare Services | -1.19% | |
| Pharma | -1.45% | |
| Medical Equipment | -3.00% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 18.7%, which is higher than its past year's earnings decline of 18.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 49% over the next 5 years.
- This is better than its past earnings decline of 9.3% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 4.1% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AP4 Riverstone Holdings | S$0.85 | 2.4% +S$29.6m | 26.7% | PE20.8x | |
| 5WA OUE Healthcare | S$0.038 | 8.6% +S$13.3m | 52.0% | PS1.1x | |
| 1D4 Aoxin Q & M Dental Group | S$0.24 | 4.3% +S$11.6m | 456.8% | PE213.3x | |
| 9G2 Singapore Institute of Advanced Medicine Holdings | S$0.03 | -14.3% S$8.6m | 3.5% | PS3.2x | |
| 1H3 Clearbridge Health | S$0.002 | 100.0% +S$6.4m | -33.3% | PS1.3x |